Abstract:Abstract Background Many patients experience primary treatment resistance when treated with ustekinumab for ulcerative colitis (UC). Predictive clinical parameters would allow such individuals to be identified pre-treatment so alternative strategies could be initiated. We explored the utility of the different histological features present in baseline samples to predict ustekinumab resistance. Methods We assessed the total Geboes score (TG) (0–22, least to most severe), and the epithelial and lamina propria neutrophil subscores (EpiN and LpN, respectively) (both 0–3) in a subset of patients with moderate-to-severely active UC (n = 448) enrolled in the phase 3 UNIFI study that evaluated the efficacy of ustekinumab therapy. We explored the relationships between histological parameters and clinical indices of activity, including faecal calprotectin (FCP), CRP, Mayo score, and treatment outcomes (clinical remission, endoscopic healing and mucosal healing at week 8, and disease clearance, which combines these all) using Spearman rank correlation. Area under the receiver operating characteristic curve (AUC) analyses were performed (presented with 95% confidence interval, CI). Analyses were performed using R 4.2.3 (Vienna, Austria) and GraphPad Prism (v 9.5.1). Results TG correlated highly with EpiN (ρ = 0.804, p < 0.0001) but did not correlate with LpN (ρ = 0.082, p = 0.07). Neither EpiN (ρ = 0.081, p = 0.09) nor LpN (ρ = -0.011, P = 0.82) correlated with FCP, though EpiN correlated weakly with log10FCP (ρ = 0.113, p = 0.017). Full Mayo score correlated with EpiN (ρ = 0.23, p < 0.0001) and TG (ρ = 0.23, < 0.0001). Of the patients with pre-treatment EpiN of 0, 23.1%, 26.9%, 23.1% and 19.2% experienced clinical remission, endoscopic healing, mucosal healing and disease clearance, respectively. Response rates incrementally reduced as EpiN increased, such that 4.2%, 12.5%, 8.3% and 4.2% of patients with EpiN of 3 achieved these outcomes, respectively. Similar trends were seen with tertiles of TG, though not with LpN. EpiN and TG predict mucosal healing with AUC 0.59 (CI: 0.50 - 0.68; p = 0.044) and 0.61 (CI: 0.52 - 0.70; p = 0.016), respectively. The addition of other clinical variables did not improve performance of the models. Conclusion There is weak or insignificant correlation between Geboes score parameters and other clinical indices of UC activity. EpiN and TG, but not LpN, stratify patients’ response to ustekinumab, with almost 6-fold difference in clinical remission between high and low EpiN. TG and EpiN predict resistance to ustekinumab, suggesting that the epithelial inflammatory milieu may be key to driving resistance to ustekinumab and possibly other therapies. This supports recent evidence highlighting the role of neutrophils in resistant UC.

P385 Epithelial neutrophil localization and Claudin-2 immunohistochemical "leaky gut" expression are innovative predictors of outcomes in Ulcerative Colitis patients in endoscopic remission

Epithelial neutrophil localization and tight junction Claudin-2 expression are innovative outcome predictors in inflammatory bowel disease

P475 Potential of molecular remission: tissue neutrophil elastase is better than histological activity for predicting long-term relapse in patients with Ulcerative Colitis in endoscopic remission

P279 Excessive accumulation of neutrophils in the epithelium, but not lamina propria, predicts resistance to ustekinumab in ulcerative colitis

The Potential of Molecular Remission: Tissue Neutrophil Elastase Is Better Than Histological Activity for Predicting Long-Term Relapse in Patients With Ulcerative Colitis in Endoscopic Remission

Exploring Predictive Biomarkers of Relapse in Ulcerative Colitis: A Proteomics Approach

P152 Longitudinal immune profiling of peripheral blood in patients with Ulcerative Colitis

CD177+ Neutrophils and Its Correlation with Mucosal Impairment in Patients with Inflammatory Bowel Disease

Targeted Assessment of Mucosal Immune Gene Expression Predicts Clinical Outcomes in Children with Ulcerative Colitis

P431 Assessing intestinal barrier healing by fusing ultra-high magnification endoscope and automated spatial multispectral imaging analysis in PSC-colitis patients

Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis—An Exploratory Study to Define Deep Remission

P336 Exploring Extracellular Matrix Markers in Ulcerative Colitis: Degradation and Formation Insights

DOP21 Histo-endoscopic remission (HEMR) Predicts Future Relapse in Patients with Ulcerative Colitis and is Associated with Lower Colectomy Risk

P219 Prognostic potential of mucosal proteins in Ulcerative Colitis

P138 Novel serum markers for predicting disease activity in ulcerative colitis: results from a retrospective case-control study

Claudin-2: A marker for a better evaluation of histological mucosal healing in inflammatory bowel diseases

P021 Higher TNFα and IL-6 mucosal levels in ulcerative colitis patients with more severe endoscopic activity

P412 Faecal Calprotectin as a predictor of endoscopic and histologic remission in patients with Ulcerative Colitis

P252 Low adherence is associated with worse disease course in Ulcerative Colitis: a retrospective study from a single referral center

Circulating Extracellular Matrix Products as Indicators of Disease Burden and Predictors of Disease Course in Ulcerative Colitis

P040 Prediction of endoscopic features of disease from single-cell RNA sequencing data in sigmoid colon of patients with ulcerative colitis